Literature DB >> 7790077

Rats clearing a vaginal infection by Candida albicans acquire specific, antibody-mediated resistance to vaginal reinfection.

A Cassone1, M Boccanera, D Adriani, G Santoni, F De Bernardis.   

Abstract

Oophorectomized, estrogen-treated rats were susceptible to experimental vaginal infection by Candida albicans. After spontaneous clearing of the primary infection, the animals were highly resistant to a second vaginal challenge with the fungus. The vaginal fluid of Candida-resistant rats contained antibodies directed against mannan constituents and secretory aspartyl proteinase(s) of C. albicans and was capable of transferring a degree of anti-Candida protection to naive, nonimmunized rats. This passive protection was mediated by the immunoglobulin fraction of the vaginal fluid and was substantially abolished by preabsorption of the vaginal fluid with C. albicans, but not with Saccharomyces cerevisiae, cells. Vaginal anti-mannan antibodies were also produced by active immunization with heat-killed cells of C. albicans or with a mannan extract when administered via the vaginal route. The protection conferred was comparable to that resulting from clearing of the primary infection. In summary, the data suggest that acquired anticandidal protection in this vaginitis model is mediated at least in part by antibodies, among which those directed against the mannan antigen(s) might play a dominant role.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7790077      PMCID: PMC173351          DOI: 10.1128/iai.63.7.2619-2624.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

Review 1.  Cell wall of Candida albicans: its functions and its impact on the host.

Authors:  A Cassone
Journal:  Curr Top Med Mycol       Date:  1989

2.  Immunology of recurrent vaginitis.

Authors:  S S Witkin
Journal:  Am J Reprod Immunol Microbiol       Date:  1987-09

Review 3.  Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis.

Authors:  J D Sobel
Journal:  Am J Obstet Gynecol       Date:  1985-08-01       Impact factor: 8.661

Review 4.  Candida cell wall mannan: a polysaccharide with diverse immunologic properties.

Authors:  J E Domer
Journal:  Crit Rev Microbiol       Date:  1989       Impact factor: 7.624

5.  Evidence for a correlation between proteinase secretion and vulvovaginal candidosis.

Authors:  A Cassone; F De Bernardis; F Mondello; T Ceddia; L Agatensi
Journal:  J Infect Dis       Date:  1987-11       Impact factor: 5.226

6.  Quantification of vaginal Candida albicans infections in rodents.

Authors:  J F Ryley; S McGregor
Journal:  J Med Vet Mycol       Date:  1986-12

7.  Inhibition of Candida albicans--induced lymphocyte proliferation by lymphocytes and sera from women with recurrent vaginitis.

Authors:  S S Witkin; I R Yu; W J Ledger
Journal:  Am J Obstet Gynecol       Date:  1983-12-01       Impact factor: 8.661

8.  Mice immunized by primary vaginal Candida albicans infection develop acquired vaginal mucosal immunity.

Authors:  P L Fidel; M E Lynch; D H Conaway; L Tait; J D Sobel
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

9.  Experimental chronic vaginal candidosis in rats.

Authors:  J D Sobel; G Muller; J F McCormick
Journal:  Sabouraudia       Date:  1985-06

10.  Isolation, acid proteinase secretion, and experimental pathogenicity of Candida parapsilosis from outpatients with vaginitis.

Authors:  F De Bernardis; R Lorenzini; R Verticchio; L Agatensi; A Cassone
Journal:  J Clin Microbiol       Date:  1989-11       Impact factor: 5.948

View more
  36 in total

1.  In vivo analysis of secreted aspartyl proteinase expression in human oral candidiasis.

Authors:  J R Naglik; G Newport; T C White; L L Fernandes-Naglik; J S Greenspan; D Greenspan; S P Sweet; S J Challacombe; N Agabian
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Candida albicans-derived beta-1,2-linked mannooligosaccharides induce desensitization of macrophages.

Authors:  T Jouault; C Fradin; P A Trinel; D Poulain
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

3.  Biochemical characterization of Candida albicans epitopes that can elicit protective and nonprotective antibodies.

Authors:  Y Han; T Kanbe; R Cherniak; J E Cutler
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

4.  Phenotypic and functional characterization of vaginal dendritic cells in a rat model of Candida albicans vaginitis.

Authors:  Flavia De Bernardis; Roberta Lucciarini; Maria Boccanera; Consuelo Amantini; Silvia Arancia; Stefania Morrone; Michela Mosca; Antonio Cassone; Giorgio Santoni
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

Review 5.  Anticandidal immunity and vaginitis: novel opportunities for immune intervention.

Authors:  Antonio Cassone; Flavia De Bernardis; Giorgio Santoni
Journal:  Infect Immun       Date:  2007-06-11       Impact factor: 3.441

6.  Women with recurrent vaginal candidosis have normal peripheral blood B and T lymphocyte subset levels.

Authors:  D J White; M Stevenson; M Shahmanesh; T Gentle
Journal:  Genitourin Med       Date:  1997-12

Review 7.  Surface glycans of Candida albicans and other pathogenic fungi: physiological roles, clinical uses, and experimental challenges.

Authors:  James Masuoka
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

8.  A vaccine and monoclonal antibodies that enhance mouse resistance to Candida albicans vaginal infection.

Authors:  Y Han; R P Morrison; J E Cutler
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

9.  Candida-specific antibodies during experimental vaginal candidiasis in mice.

Authors:  Karen L Wozniak; Floyd L Wormley; Paul L Fidel
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

10.  Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated Candidiasis in recipients of a Candida albicans vaccine.

Authors:  Carla Bromuro; Antonella Torosantucci; Paola Chiani; Stefania Conti; Luciano Polonelli; Antonio Cassone
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.